Imajuku, Japan

Jin-ichi Inokuchi

This inventor holds 1 USPTO granted patent. Top assignee: University of Michigan. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jin-ichi Inokuchi. Retrieved from https://idiyas.com/inventor/jin-ichi-inokuchi-iavanh40

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jin-ichi Inokuchi in Chemotherapy

Introduction

Jin-ichi Inokuchi is a notable inventor based in Imajuku, Japan. She has made significant contributions to the field of chemotherapy through her innovative research and patent.

Latest Patents

Inokuchi holds a patent for a method of chemotherapy that utilizes an inhibitor of glycosphingolipid metabolism as a chemotherapeutic agent against cancer. This method can also be applied to treat other conditions caused by cell proliferation sensitive to glycosphingolipid metabolism inhibition. A preferred inhibitor identified in her patent is 1-phenyl-2-acylamino-3-morpholino-1-propanol. This innovative approach has the potential to enhance cancer treatment efficacy.

Career Highlights

Jin-ichi Inokuchi is affiliated with the University of Michigan, where she continues her research and development in the field of cancer treatment. Her work has garnered attention for its potential impact on improving therapeutic strategies.

Collaborations

Inokuchi collaborates with Norman S Radin, contributing to advancements in their shared field of research. Their partnership exemplifies the importance of teamwork in scientific innovation.

Conclusion

Jin-ichi Inokuchi's contributions to chemotherapy through her innovative patent highlight her role as a significant inventor in the medical field. Her work continues to inspire advancements in cancer treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…